The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Oral Session

Oral Session 2-11B AML: Novel therapeutic targets

Sat. Oct 13, 2018 10:10 AM - 11:10 AM No.11 (Osaka International Convention Center, 10F 1004-5)

Chair: Yoichi Imai (Research Hospital, The Instisute of Medical Science, The University of Tokyo, Japan)

[OS2-11B-3] The circadian modulating drug exhibits an anti-leukemia effect through the mitochondrial oxidation

Tomoko Hyoda1, Yuya Kunisaki2, Kentaro Hosokawa2, Tsuyoshi Hirota3, Kazuhito Gotoh4, Daiki Setoyama4, Dongchon Kang4, Fumio Arai2 (1.Health Science, Kyushu Univ., Fukuoka, Japan, 2.Stem Cell Biology, Kyushu Univ., Fukuoka, Japan, 3.Transformative Bio-Molecules, Nagoya Univ., Japan, 4.Clinical Chemistry and Laboratory Medicine, Kyushu Univ., Japan)

Abstract password authentication.
Password is written on a program and abstract book.

Password